0000950170-24-064235.txt : 20240523 0000950170-24-064235.hdr.sgml : 20240523 20240523193040 ACCESSION NUMBER: 0000950170-24-064235 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240522 FILED AS OF DATE: 20240523 DATE AS OF CHANGE: 20240523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLARKE JOHN K CENTRAL INDEX KEY: 0001219015 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37378 FILM NUMBER: 24980377 MAIL ADDRESS: STREET 1: C/O CARDINAL HEALTH PARTNERS STREET 2: 221 NASSAU STREET CITY: PRINCETON STATE: NJ ZIP: 08542 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: aTYR PHARMA INC CENTRAL INDEX KEY: 0001339970 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 203435077 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10240 SORRENTO VALLEY ROAD STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8587318389 MAIL ADDRESS: STREET 1: 10240 SORRENTO VALLEY ROAD STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 ownership.xml 4 X0508 4 2024-05-22 0001339970 aTYR PHARMA INC LIFE 0001219015 CLARKE JOHN K C/O ATYR PHARMA, INC. 10240 SORRENTO VALLEY ROAD, SUITE 300 SAN DIEGO CA 92121 true false false false false Stock Option (right to buy) 1.86 2024-05-22 4 A false 24000 0.00 A 2034-05-22 Common Stock 24000 24000 D The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. /s/ Nancy E. Denyes, as Attorney-in-Fact 2024-05-23